Cita APA

Wrishko, R. E., McCrea, J. B., Yee, K. L., Liu, W., Panebianco, D., Mangin, E., . . . Kraft, W. K. (2019). Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open‑Label, Fixed-Sequence Trials in Healthy Subjects. Clin Drug Investig.

Chicago Style Citation

Wrishko, Rebecca E., Jacqueline B. McCrea, Ka Lai Yee, Wen Liu, Deborah Panebianco, Eric Mangin, Manu Chakravarthy, Maria P. Martinez-Cantarin, i Walter K. Kraft. "Effect of CYP3A Inhibition and Induction On the Pharmacokinetics of Suvorexant: Two Phase I, Open‑Label, Fixed-Sequence Trials in Healthy Subjects." Clin Drug Investig 2019.

Cita MLA

Wrishko, Rebecca E., et al. "Effect of CYP3A Inhibition and Induction On the Pharmacokinetics of Suvorexant: Two Phase I, Open‑Label, Fixed-Sequence Trials in Healthy Subjects." Clin Drug Investig 2019.

Atenció: Aquestes cites poden no estar 100% correctes.